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Arf6 controls retromer traffic and
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Small GTPases play a critical role in membrane traffic. Among them, Arf6 mediates transport
to and from the plasma membrane, as well as phosphoinositide signalling and cholesterol
homeostasis. Here we delineate the molecular basis for the link between Arf6 and cholesterol
homeostasis using an inducible knockout (KO) model of mouse embryonic fibroblasts
(MEFs). We find that accumulation of free cholesterol in the late endosomes/lysosomes of
Arf6 KO MEFs results from mistrafficking of Niemann–Pick type C protein NPC2, a cargo of
the cation-independent mannose-6-phosphate receptor (CI-M6PR). This is caused by a
selective increase in an endosomal pool of phosphatidylinositol-4-phosphate (PI4P) and a
perturbation of retromer, which controls the retrograde transport of CI-M6PR via sorting
nexins, including the PI4P effector SNX6. Finally, reducing PI4P levels in KO MEFs
through independent mechanisms rescues aberrant retromer tubulation and cholesterol
mistrafficking. Our study highlights a phosphoinositide-based mechanism for control of
cholesterol distribution via retromer.
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I
ntracellular transport routes are under strict regulatory control
in eukaryotic cells to ensure proper sorting of cargoes,
maintain organelle identity and ultimately guarantee cell
homeostasis. Among the key regulators of intracellular trafficking
pathways, small GTPases, such as ADP ribosylation factor (Arf)
family members, play a fundamental role in a compartment-
specific manner. Similar to other GTPases, Arf proteins cycle
between an inactive GDP-bound form and an active GTP-bound
form1. Unlike the other Arf family members (that is, Arf1-5),
Arf6 is uniquely localized to the plasma membrane and to
endosomes2,3, where it influences membrane trafficking. The
role of Arf6 in various clathrin-dependent and -independent
endocytic pathways as well as in recycling to the plasma
membrane has been extensively studied4,5. A role for Arf6 in
multivesicular body formation has also been recently described6.
In addition, Arf6 regulates actin remodeling in such contexts as
cell spreading, migration, cytokinesis, phagocytosis and neurite
outgrowth5,7. In vivo, Arf6 ablation is embryonically lethal in the
mouse8 but a conditional knockout (KO) model revealed a
non-cell autonomous role for neuronal Arf6 in oligodendrocyte
precursor cell migration and myelination9.
One of the major mechanisms of action of Arf6 occurs
through the control of lipid metabolism. Indeed, Arf6 binds and
activates phosphatidylinositol-4-phosphate 5-kinases (PI4P5Ks),
also known as type I PIPKs (PIPKIs), which phosphorylate PI4P
into PI(4,5)P2 (ref. 10,11). In addition, Arf6 can activate
phospholipase D (PLD)12, whose product phosphatidic acid can
in turn activate PIPKIs (ref. 13). Overexpressing a constitutively
active mutant of Arf6 (Arf6 Q67L) also results in enlarged
endosomes that contain high levels of PI(4,5)P2 (ref. 14). More
recently, Arf6 has been implicated in the regulation of cellular
cholesterol distribution. In cultured cells, most cholesterol is
derived from cholesteryl ester-rich LDL particles present in the
media. LDL-particles are internalized by the LDL receptor
(LDLR) and trafficked to the lumen of late endosomes/
lysosomes (LE/LYS). Cholesteryl esters are first hydrolysed by
lysosomal acid lipase to free cholesterol, which is believed to be
transferred by NPC2, a small soluble protein of the LE/LYS
lumen, to the polytopic membrane protein NPC1. The latter
mediates the egress of cholesterol from the endolysosomal system,
allowing for its distribution to other cellular compartments and
inhibition of cholesterol biosynthesis via the cholesterol-sensing
machinery operating in the endoplasmic reticulum15,16.
Perturbation of cholesterol traffic through mutations of NPC1
or NPC2 genes causes Niemann–Pick Type C (NPC) disease,
a fatal neurodegenerative disorder associated with accumulation
of free cholesterol and other lipids in the endolysosomal system17.
Several studies provided hints that Arf6 is involved in the control
of cholesterol homeostasis. First, Arf6 Q67L enlarged endosomes
contain high levels of free cholesterol, labelled with filipin18.
Second, silencing Arf6 was found to increase cellular cholesterol
content in HeLa cells, reminiscent of an NPC disease
phenotype19. In addition, Arf6 and components of its
interactome were identified as ‘hits’ in a transcriptomic screen
performed after cholesterol levels of cultured rat neurons were
acutely increased20. More recently, Arf6 was a hit in a genome-
wide RNA-interference screen designed to identify genes required
for intracellular transport of LDL-derived cholesterol, although
this link was not explored further21. While these studies point to a
link between Arf6 and cholesterol metabolism, the molecular
basis underlying this relationship is unknown.
To address this fundamental question, we developed a novel
model of Arf6 conditional KO in immortalized mouse embryonic
fibroblasts (MEFs). We found that Arf6 depletion leads to
cholesterol redistribution and accumulation in LE/LYS, a
phenotype due to the mistargeting of NPC2 away from
lysosomes. Because NPC2 is a cargo of the mannose-6-phosphate
receptor (M6PR)22, we examined the function of retromer, which
regulates the retrograde transport of the M6PR. We found that
retromer function is impaired in Arf6 KO cells, thus leading to
mislocalization of the cation-independent M6PR (CI)-M6PR
away from the trans-Golgi network (TGN). We also found that
PI4P levels were increased in Arf6 KO MEFs and that retromer-
positive aberrant tubules emerged in part from PI4P-containing
endosomes. Finally, we demonstrated that restoring PI4P levels
rescues aberrant retromer tubules and cholesterol accumulation.
This work therefore highlights a novel role for Arf6 in the
regulation of retromer with critical implications for PI4P and
cholesterol metabolism.
Results
Cholesterol redistributes to LE/LYS in Arf6 KO cells. To control
the ablation of Arf6 acutely and inducibly, MEFs were generated
from Arf6Flox/Flox embryos also expressing a fusion of Cre
recombinase with the ligand-binding domain of the oestrogen
receptor (Cre-ER; Supplementary Fig. 1a). After immortalization,
MEFs treated with tamoxifen showed gradually reduced levels of
Arf6 protein by western blotting, leading to a complete absence of
protein after 6 days (Fig. 1a; Supplementary Fig. 1b). We then
assessed the impact of Arf6 ablation on cholesterol. Cholesterol
content was first analysed by liquid chromatography–mass
spectrometry (LC–MS) and was similar in Arf6 WT and KO
MEFs (Fig. 1b). MEFs were subsequently stained with filipin,
a fluorescent probe for free cholesterol (Fig. 1c). The overall
filipin intensity was comparable in the two genotypes (Fig. 1d), in
agreement with the LC–MS results. However, while wild-type
(WT) cells exhibited a diffuse staining at the plasma membrane
and the cytoplasm with higher fluorescence intensity in the
perinuclear region, the pattern of filipin staining was altered in
KO MEFs, where it accumulated in cytoplasmic puncta (Fig. 1c).
Quantification of filipin fluorescence revealed there were more
cholesterol puncta in Arf6 KO cells compared with controls
(Fig. 1e). Filipin puncta in Arf6 KO MEFs also appeared
significantly larger than in the controls (Fig. 1e). Aberrant filipin
distribution could be rescued by expressing ARF6-HA (ref. 3) in
Arf6 KO cells (Supplementary Fig. 2), indicating that the
cholesterol redistribution phenotype is a direct and specific
consequence of Arf6 ablation in those cells. We then identified
the specific compartment where free cholesterol accumulated in
Arf6 KO cells. Filipin accumulated in Rab7- and LAMP1-positive
organelles but not in EEA1-positive organelles (Fig. 1f), indicating
that cholesterol is redistributed to LE/LYS but not to early
endosomes in KO cells. LAMP1 protein levels (Supplementary
Fig. 3a) as well as the number and size of LAMP1-positive
organelles (Supplementary Fig. 3b) were similar in both geno-
types, indicating that Arf6 depletion did not cause any major
structural disruption of LE/LYS.
NPC2 mistrafficking causes cholesterol redistribution. Since
the accumulation of cholesterol in LE/LYS is reminiscent of NPC
cells17, we assessed whether the localization of NPC1 and/or
NPC2 is affected by Arf6 depletion. As probed by Western blot,
NPC1 protein levels were comparable (P40.05, Student’s t-test)
in Arf6 WT (100±9%,±indicates s.e.m., n¼ 3) and Arf6 KO
cells (75±20%, n¼ 3; Supplementary Fig. 3c). NPC1-GFP
was found on the membrane of LE/LYS in both Arf6 WT and
KO cells and displayed extensive co-localization with LAMP1,
independently of Arf6 presence (Supplementary Fig. 3d),
suggesting that it is correctly trafficked in Arf6 KO cells. In
contrast, co-localization of endogenous NPC2 and LAMP1 was
greatly reduced in Arf6 KO cells compared with controls (Fig. 2a),
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although NPC2 protein levels were comparable in both
genotypes (Fig. 2b; Arf6 WT 100±6% and Arf6 KO cells
110±26%,±indicates s.e.m., n¼ 3). The reduced presence of
NPC2 in the LE/LYS compartment coincided with greater
co-localization of this protein with Golgin97, a TGN marker






























































































































































































Figure 1 | Cholesterol is redistributed to late endosomes/lysosomes in Arf6 KO MEFs. (a) Western blot analysis of endogenous Arf6 levels in
Arf6Flox/Flox; Cre-ER MEFs treated with DMSO (Arf6 WT) or tamoxifen (Arf6 KO). Tubulin was used as an equal loading marker. (b) Cholesterol levels
measured by LC–MS were similar in Arf6 WT (19.1±0.7 molar % of total lipidome,±indicates s.e.m., n¼ 11) and KO cells (18.5±0.5 molar % of total
lipidome, n¼ 12). NS denotes P40.05 in Student’s t-test. (c) Representative confocal images of Arf6 WTand KO MEFs stained with filipin. Scale bar, 5 mm.
(d) Normalized integrated densities of filipin staining were similar in Arf6 WT (100±8%,±indicates s.e.m., n¼ 32 cells from three experiments) and Arf6
KO cells (98±8%, n¼42 cells from four experiments). NS denotes P40.05 in Student’s t-test. (e) Quantification of filipin puncta in Arf6WTand KO cells.
Left panel, number of puncta per cell in Arf6 WT (13±2 puncta per cell,±indicates s.e.m., n¼ 39 cells from 3 experiments) and Arf6 KO cells (26±3
puncta per cell, n¼ 29 cells from 3 experiments). **Po0.01 in Student’s t-test. Middle panel, frequency distribution of the number of filipin puncta per cell.
***Po0.001 in w2-test. Right panel, scatter dot blot of the size of filipin puncta in Arf6 WT (0.42±0.01 mm2,±indicates s.e.m., 498 puncta from 39 cells)
and KO cells (0.47±0.01mm2, 749 puncta from 29 cells). *Po0.05 in Mann–Whitney test. (f) Representative immunostainings for EEA1, Rab7 or LAMP1
(magenta) of Arf6 WT or KO cells labelled with filipin (green). Scale bar, 5mm. NS, not significant.
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mistargeting of NPC2 and its thus reduced activity may be
responsible for cholesterol accumulation in LE/LYS. To test this,
we bypassed the anterograde pathway for delivery of NPC2 to
endosomes by exogenously adding fluorescent NPC2-Alexa488
to MEFs and monitored cholesterol distribution with filipin
(Fig. 2c). In vehicle-treated KO cells, cholesterol accumulated in
LE/LYS as expected (Fig. 2c). Exogenous NPC2 was able to be
internalized and reach the LAMP1-positive LE/LYS compartment
and, remarkably, decreased both the number and size of filipin
puncta in the Arf6 KO cells (Fig. 2c), corroborating our
hypothesis that Arf6 depletion induces cholesterol redistribution
to LE/LYS through NPC2 mistrafficking.
Mislocalisation of CI-M6PR causes mistrafficking of NPC2.
NPC2 trafficking was reported to be dependent on M6PRs,
with a more significant contribution of CI-M6PR relative to
cation-dependent-M6PR (ref. 22). CI-M6PR cycles between the










































































































































Figure 2 | NPC2 mistrafficking causes cholesterol redistribution in Arf6 KOMEFs. (a) Left panel, representative confocal images of Arf6WTand KO cells
immunostained for endogenous LAMP1 (magenta) and NPC2 (green). Scale bar, 5 mm. Right panel, NPC2/LAMP1 co-localization levels in Arf6 WT
(23±1%,±indicates s.e.m., n¼ 36 cells from three experiments) and Arf6 KO cells (16±1%, n¼ 24 cells from three experiments). ***Po0.001 in
Student’s t-test. (b) Western blot analysis of endogenous NPC2 levels in Arf6 WTand KO cells. Tubulin was used as an equal loading marker. NPC2 protein
levels were similar (P40.05 in Student’s t-test) in Arf6 WT (100±6%,±indicates s.e.m., n¼ 3) and KO cells (110±26%, n¼ 3). (c) NPC2-Alexa488
(green) or vehicle was added to the culture media of Arf6 WT and KO cells for 24 h. Cells were then washed, fixed and stained for endogenous LAMP1
(magenta) and cholesterol (with filipin, blue). Left panel, representative confocal images. Scale bar, 5 mm. Inset shows that exogenous NPC2 reaches the
LAMP1 compartment. Center and right panel, quantification of filipin puncta. Center, number of filipin puncta in vehicle-treated Arf6 WT (16±2 puncta per
cell,±indicates s.e.m., n¼ 34 cells, three experiments), vehicle-treated KO (24±3 puncta per cell, n¼ 35 cells, three experiments), NPC2-treated Arf6 WT
(18±2 puncta per cell, n¼ 36 cells, three experiments) and NPC2-treated KO cells (18±5 puncta per cell, n¼ 28 cells, three experiments). NS and * stand
for P40.05 and Po0.05, respectively, in t-test with Welch’s correction. Right, scatter dot blot of the size of filipin puncta of vehicle-treated Arf6 WT
(0.41±0.01mm2,±indicates s.e.m., 540 puncta from 34 cells), vehicle-treated Arf6 KO (0.48±0.01mm2, 843 puncta from 35 cells), NPC2-treated Arf6
WT (0.46±0.01mm2, 663 puncta from 36 cells) and NPC2-treated Arf6 KO cells (0.45±0.01mm2, 496 puncta from 28 cells). NS denote P40.05,
*Po0.05 and ***Po0.001 in Mann–Whitney test, respectively. NS, not significant.
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soluble lysosomal proteins, including hydrolases. The latter are
then released in endosomes as a result of a lower pH and
passively delivered to the LE/LYS where their function is needed.
The retrograde transport of CI-M6PR from endosomes to the
TGN is mediated primarily by the retromer complex23,24. We
thus investigated whether NPC2 mistrafficking resulted from
deficits in the traffic of CI-M6PR. In Arf6WT cells, CI-M6PR was
highly concentrated in the perinuclear region, in accordance with
previous reports that it primarily accumulates in the TGN at
steady state25 (Fig. 3a). However, in Arf6 KO cells, CI-M6PR
appeared more dispersed and was present not only in the TGN
area but also on vesicular structures that were positive for Vps35,
the core component of retromer (Fig. 3a).
The retromer complex function is impaired in Arf6 KO cells.
We then asked whether CI-M6PR mislocalization was due to a
deficit in its retrograde transport caused by a malfunction of
the retromer. The retromer complex is composed of two sub-
complexes. The cargo-selective core subcomplex, composed of
Vps35, Vps29 and Vps26, is involved in cargo recognition and
sorting. The membrane-deforming subcomplex, composed of a
sorting nexin (SNX) heterodimer, is involved in tubulo-vesicular
carrier formation from endosomal membranes26. In the case
of CI-M6PR transport, the specific SNX isoforms involved
are heterodimers of SNX1 or SNX2 and SNX5 or SNX6
(refs 23,27–30).
We thus examined the relationship between Arf6 and retromer
using confocal microscopy. Because various antibodies failed to
specifically recognize endogenous Arf6 in immunofluorescence
applications, two different ARF6 constructs, ARF6-HA (ref. 3)
and CyPET-ARF6 (ref. 31), were exogenously expressed in HeLa
cells, which were then stained for VPS35. A pool of Arf6 and
retromer were found on the same endosomal compartments,
suggesting a potential functional interaction (Supplementary
Fig. 5). We then assessed the potential impact of Arf6 deletion on
retromer levels by focusing on the core subunit of retromer and
found that Vps35 protein levels were similar in Arf6 WT and KO
cells (Fig. 3b). However, the co-localization between Vps35 and
EEA1, an early endosome marker, was increased in Arf6 KO cells,
compared with WT cells (15% versus 10%, respectively, Fig. 3c,d),
showing that retromer was partially redistributed to early
endosomes. While the number of tubulo-vesicular Vps35-positive
retromer carriers was comparable, their size was increased in
Arf6 KO cells (Fig. 3e). In contrast, the number and size of EEA1-
positive early endosomes were similar in both genotypes (Fig. 3e).
When visualized with super-resolution three-dimensional
(3D)-Structured Illumination Microscopy (SIM), the size of
retromer tubulo-vesicular carriers appeared larger in Arf6 KO
cells, where Vps35 and EEA1 formed a continuous alveolar-
shaped endosomal network (Fig. 3f; Supplementary Movies 1–4).
To test for potential changes in the dynamics of retromer
tubules, we transfected MEFs with GFP-SNX6 and imaged them
by spinning-disk microscopy (Supplementary Movies 5 and 6).
As shown in Fig. 3g, there were more GFP-SNX6-positive tubules
in Arf6 KO cells than in controls, and these tubules were both
longer and more persistent. SNX6 tubules were still able to move
towards the perinuclear region in Arf6 KO cells (Supplementary
Movies 6), indicating no gross malfunction of molecular
motors/microtubules transport. Altogether, our data suggest that
Arf6 ablation causes alterations in retromer tubule dynamics,
which are consistent with fission defects.
Retromer knockdown causes cholesterol increase in LE/LYS.
Our data suggest that Arf6 deletion causes a retromer defect
which in turn leads to aberrant localization of CI-M6PR and its
cargo NPC2 and finally to accumulation of cholesterol in LE/LYS.
If this hypothesis is correct, then retromer deficiency should
mimic the cholesterol phenotype observed in Arf6 KO cells. We
thus treated HeLa cells with small interfering (siRNAs) to VPS35
and monitored the cholesterol distribution. After VPS35 siRNA
transfection (VPS35 KD), VPS35 protein levels were decreased to
22±11% (± indicates s.e.m., n¼ 3) of those found in scramble
siRNA-transfected cells, as assessed by western blot (Fig. 4a).
Cells treated with siRNAs were fixed, immunostained for LAMP1
and VPS35 and labelled with filipin (Fig. 4b). Unlike Arf6 KO
MEFs, VPS35 KD HeLa cells showed an overall increase in the
levels of free cholesterol (Fig. 4c). However, similar to our
observations in Arf6 KO cells, filipin accumulated primarily in
large LAMP1-positive puncta (Fig. 4b). Quantification of filipin
puncta showed that there was on averageB77% more puncta/cell
in VPS35 KD cells and that there was a significant shift in the
relative distribution towards cells with a very large number of
puncta (30 or more; Fig. 4d). Filipin puncta were also significantly
larger in VPS35 KD cells than in controls (Fig. 4e). An increase in
the number of filipin puncta was also observed when HeLa cells
were treated with siRNAs targeting SNX1 and SNX2 or SNX5 and
SNX6, the main sorting nexin isoforms involved in CI-M6PR
trafficking23,27–30 (Supplementary Fig. 6). Taken together, these
results show that depletion of retromer causes an increase in
cholesterol levels and an accumulation of cholesterol in the
LE/LYS compartment, consistent with our hypothesis. The
retromer KD phenotype appears to be slightly more marked
than the Arf6 KO phenotype vis-a`-vis global cholesterol
accumulation, perhaps reflecting the impact of a full versus a
partial loss of function of retromer in VPS35 KD HeLa cells and
Arf6 KO MEFs, respectively.
PI4P accumulates on retromer-positive early endosomes.
To further delineate the molecular mechanisms underlying the
retromer defect in Arf6 KO cells, we attempted to identify the
Arf6 effector responsible for this phenotype. As stated earlier,
some of the key effectors of Arf6 are PIPKIs, which catalyse the
phosphorylation of PI4P into PI(4,5)P2 (refs 10,11). We
thus analysed the anionic phospholipid content of MEFs by
HPLC combined with suppressed conductivity. Interestingly,
we observed a B20% increase in PI4P in Arf6 KO cells, with
no changes in phosphatidylserine, cardiolipin, PI or, more
intriguingly, PI(4,5)P2 (Fig. 5a). As it was reported that phos-
phatidic acid levels could also play a role in PIPKIs regulation13,
we measured phosphatidic acid levels by HPLC and LC–MS.
Phosphatidic acid levels measured by HPLC were similar
(P40.05, Student’s t-test) in Arf6 WT (100±3 normalized
molar % of measured lipids,±indicates s.e.m., n¼ 3) and Arf6
KO cells (108±16 normalized molar % of measured lipids,
n¼ 3). Similarly, phosphatidic acid levels measured by LC–MS
were comparable (P40.05, Student’s t-test) in Arf6 WT
(0.077±0.010 molar % of measured lipids,±indicates s.e.m.,
n¼ 11) and Arf6 KO cells (0.064±0.007 molar % of measured
lipids, n¼ 12), making an indirect contribution of PLD unlikely.
Further investigation of PI4P levels by immunofluorescence
also revealed a striking approximately twofold increase in PI4P
fluorescence in Arf6 KO MEFs relative to controls (Fig. 5b). As
expected32, a large pool of PI4P co-localized with the TGN
marker Golgin97 in both genotypes (Fig. 5b). However, as
recently reported by others33, PI4P was also present on more
peripheral compartments likely corresponding to endosomes
(Fig. 5b). We thus tested whether some of these PI4P-positive
compartments are early endosomes by co-immunostaining MEFs
for PI4P and EEA1 and found that the co-localization between
PI4P and EEA1 was increased by twofold in Arf6 KO cells
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compared with controls (Fig. 5c). PI4P thus markedly
accumulates on early endosomes. We also assessed whether
PI4P accumulates on endosomal pools where retromer is present
by immunostaining MEFs for endogenous PI4P and SNX6. We
found not only that the overall PI4P/SNX6 co-localization was
increased in Arf6 KO cells compared with WT cells (Fig. 5d, right
panel) but also that the cellular region where this co-localization
took place was different (Fig. 5d, left panel). While in Arf6 WT
cells, PI4P and SNX6 mostly co-localized in the perinuclear
region, they also co-localized in more peripheral compartments in
Arf6 KO cells (Fig. 5d, insets). Comparable results were obtained
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Figure 4 | Cholesterol is redistributed to late endosomes/lysosomes in VPS35 KD HeLa cells. (a) Western blot analysis of VPS35 levels in HeLa cells
transfected with scramble or VPS35 siRNA. Tubulin was used as an equal loading marker. (b) Representative confocal images of HeLa cells transfected with
scramble or VPS35 siRNA, immunostained for LAMP1 (magenta) and VPS35 (green) and labelled with filipin (blue). Scale bar, 5 mm. (c) Normalized
integrated densities of filipin staining in scramble (100±5%,±indicates s.e.m., n¼ 29 cells, three experiments) and VPS35 siRNA cells (124±9%, n¼ 28
cells, three experiments). *Po0.05 in t-test with Welch’s correction. (d) Quantification (left) and frequency distribution (right) of the number of filipin
puncta in scramble (22±4 puncta per cell,± indicates s.e.m., n¼ 33 cells, three experiments) and VPS35 siRNA cells (39±5 puncta per cell, n¼ 32 cells,
three experiments). *Po0.05 in Student’s t-test and ***Po0.001 in w2-test. (e) Scatter dot blot of the size of filipin puncta in scramble (0.71±0.03mm2,
± indicates s.e.m., 741 puncta from 33 cells) and VPS35 siRNA cells (0.73±0.02mm2, 1,241 puncta from 32 cells). **Po0.01 in Mann–Whitney test.
Figure 3 | Retromer function is impaired in Arf6 KO MEFs. (a) Representative maximum intensity projections of Arf6 WTand KO cells immunostained for
CI-M6PR (magenta) and Vps35 (green). Scale bar, 5 mm. (b) Western blot analysis of Vps35 levels in Arf6 WT (100±5%, n¼ 5) and KO cells (113±5%,
n¼ 5), P40.05 in Student’s t-test. Tubulin was used as an equal loading marker. (c) Representative confocal images of Arf6 WT and KO cells
immunostained for EEA1 (magenta) and Vps35 (green). Scale bar, 5 mm. (d) Levels of Vps35/EEA1 co-localization in Arf6 WT (10±1%, n¼ 26 cells) and
KO cells (15±1%, n¼ 30 cells). **Po0.01 in t-test with Welch’s correction. (e) Top left panel, number of Vps35 puncta in Arf6 WT (116±8 puncta per cell,
n¼ 28 cells) and KO cells (126±6 puncta per cell, n¼ 28 cells). ns stands for P40.05 in Student’s t-test. Top right, size of Vps35 puncta in WT
(0.53±0.01mm2, 3,241 puncta) and KO cells (0.59±0.01mm2, 3,529 puncta). ** stands for Po0.01 in Mann–Whitney test. Bottom left, number of EEA1
puncta in WT (235±12 puncta per cell, n¼ 28 cells) and KO cells (232±13 puncta per cell, n¼ 23 cells). Bottom right, size of EEA1 puncta in WT
(0.40±0.01mm2, 6,571 puncta) and KO cells (0.39±0.01mm2, 5,334 puncta). ns stands for P40.05 in Student’s t-test (left) and Mann–Whitney test
(right). (f) Maximum intensity projections of 3D SIM z-stacks of Arf6 WTand KO cells immunostained for EEA1 (magenta) and Vps35 (green). Scale bar,
5 mm. (g) Spinning-disk confocal imaging of Arf6 WTand KO MEFs expressing GFP-SNX6. Top panel, representative images. Scale bar, 5 and 1 mm (insets).
Arrows indicate tubules. Lower panel, quantification of GFP-SNX6 tubules. Left, number of GFP-SNX6 tubules in Arf6 WT (3±0.3 tubules per cell, n¼ 21
cells) and KO cells (4.5±0.6 tubules per cell, n¼ 22 cells). *Po0.05 in t-test with Welch’s correction. Center, frequency distribution of GFP-SNX6 tubules
length in Arf6 WT (2.6±0.2 mm, n¼63 tubules) and KO cells (3.2±0.2 mm, n¼ 97 tubules). ***Po0.001 in w2-test. Right, persistence of GFP-SNX6
tubules in Arf6 WT (11.6±1.8 s, n¼ 62 tubules) and KO cells (24.1±2.9 s, n¼97 tubules). ***Po0.001 in t-test with Welch’s correction. All values are
given as mean±s.e.m.
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core component Vps35 (Supplementary Fig. 7). We thus
concluded that in Arf6 KO cells, both PI4P and the retromer
complex accumulate on endosomes.
Lowering PI4P levels rescues retromer function. These data led
us to postulate that endosomal PI4P accumulation may be
responsible for the defect in retromer tubules dynamics observed
in Arf6 KO cells (Fig. 3g). To test this, we used phenylarsine oxide
(PAO), a PI4K inhibitor34, to lower the levels of PI4P. After
30min of 1 mM PAO treatment, levels of PI4P in Arf6 KO cells
decreased by B20% and B35%, as assessed by immunostaining
and HPLC, respectively (Fig. 6a,b). We quantified the number of
GFP-SNX6 tubules in cells treated with dimethyl sulfoxide
(DMSO) or PAO and visualized by spinning-disk microscopy
(Fig. 6c; Supplementary Movies 7–9). At time 0, both sets of cells
had a similar number of tubules (P40.05, t-test with Welch’s
correction). The number of GFP-SNX6 tubules in DMSO-treated
Arf6 KO MEFs was unchanged with time (P40.05, one-way
analysis of variance (ANOVA)). In contrast, PAO-treated Arf6
KO cells showed a decreased number of tubules after 15min of
treatment (40±12% of the number of tubules at time 0,
± indicates s.e.m.) and this decrease was even more
pronounced after 30min of treatment (33±8% of the number
of tubules at time 0). Decreasing the levels of PI4P can thus rescue
the defect in retromer tubule dynamics.
Lowering PI4P levels rescues cholesterol redistribution. To test
whether PI4P increase is also the cause of cholesterol accumu-
lation in the LE/LYS of Arf6 KO cells, we assessed the impact of
lowering PI4P levels on cholesterol localization using different
but complementary approaches. First, we used PAO treatment
and labelled cells for PI4P and filipin (Fig. 6d). After 30min of
treatment, the average number of filipin puncta per cell was
slightly decreased, although it did not reach significance.
However, the quantification revealed a shift towards cells with a
lower number of puncta in the relative distribution (Fig. 6d,
center). The average size of filipin puncta was reduced with a
specific decrease in the number of large (1.5-2.5 mm2) puncta
(Fig. 6d, right). This partial rescue of cholesterol distribution was
accompanied by a normalization of CI-M6PR distribution and an
increase in NPC2/LAMP1 co-localization after PAO treatment
(Supplementary Fig. 8b,c). Next, we overexpressed wild-type
GFP-PIPKIgi1 (WT) or its kinase-dead K188A mutant in
Arf6 KO MEFs (Fig. 7a). Quantification of filipin fluorescence in
transfected cells after 48 h showed fewer filipin puncta of smaller
size in WT-transfected cells (Fig. 7a). The kinase activity of
PIPKIgi1 was thus required to rescue the cholesterol redistribu-
tion phenotype. To rule out that the changes in cholesterol
distribution observed in the Arf6 KO were not due to the
PI(4,5)P2 levels increase we surprisingly observed after PAO












































































































































Figure 5 | PI4P is increased in Arf6 KO cells and accumulates in retromer-positive endosomes. (a) Bar diagram showing lipid levels in Arf6 WTand KO
cells. Measurements were made by anionic exchange HPLC with suppressed conductivity detection, expressed in molar percentage of total anionic
phospholipid measured and normalized to Arf6 WT levels. PI4P levels were increased in Arf6 KO cells (121±5%,± indicates s.e.m., n¼9) compared with
controls (100±5%, n¼ 9). **Po0.01 in Student’s t-test. (b) Left, representative confocal images of Arf6 WT and KO cells immunostained for PI4P
(magenta) and Golgin97 (green). Scale bar, 5 mm. Right, normalized integrated densities of PI4P staining were increased in Arf6 KO cells (191±23%,
± indicates s.e.m., n¼ 27 cells, three experiments) compared to controls (100±12%, n¼ 22 cells, three experiments). **Po0.01 in t-test with Welch’s
correction. (c) Left, representative confocal images of Arf6 WTand KO cells immunostained for PI4P (magenta) and EEA1 (green). Scale bar, 5 mm. Right,
PI4P/EEA1 co-localization levels in Arf6 WT (7±1%, ± indicates s.e.m., n¼ 25 cells, three experiments) and KO cells (13±1%, n¼ 22 cells, three
experiments). ***Po0.001 in Student’s t-test. (d) Left, representative confocal images of Arf6 WT and KO cells immunostained for PI4P (magenta) and
SNX6 (green). Scale bar, 5 mm. Right, PI4P/SNX6 co-localization levels in WT (7±1%, ± indicates s.e.m., n¼ 33 cells, three experiments) and KO cells
(11±2%, n¼ 24 cells, three experiments). *Po0.05 in Student’s t-test.
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selectively decrease PI4P levels in endosomes by exploiting the
recently characterized endosomal PI4P-phosphatase Sac2
(refs 35,36) as a tool. We overexpressed wild-type GFP-Sac2
(WT) or its phosphatase-dead C458S mutant in Arf6 KO MEFs
(Fig. 7b) and found that filipin puncta were fewer and of smaller
size in WT GFP-Sac2 transfected cells (Fig. 7b). Cholesterol
distribution rescue was thus dependent on the PI4P-phosphatase
activity of Sac2. Altogether, these three approaches highlight the
role of elevated PI4P levels in cholesterol accumulation in LE/LYS
of Arf6 KO cells.
Discussion
Arf6 has been implicated in various aspects of cell physiology,
primarily as a regulator of vesicular transport to and from the
plasma membrane4,5. A key function of Arf6, however, appears to
be the control of lipid signalling and, in particular,
phosphoinositide signalling11. Parallel studies have also hinted
that Arf6 may control cholesterol homeostasis, yet, through
unknown mechanisms18–21. This study mechanistically links
these disconnected bodies of literature, by identifying a
phosphoinositide-based mechanism for the control of
intracellular cholesterol distribution via the retromer pathway.
It is to our knowledge the first time that Arf6 is shown to
regulate retromer function, although at least two previous studies
presented circumstantial evidence consistent with this idea. First,
even before retromer was identified, CI-M6PR was described as
being present on Arf6-positive endosomes, but the functional
relationship between these two proteins was not addressed3.
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Figure 6 | Lowering PI4P levels with PAO rescues excessive retromer tubulation and cholesterol accumulation in LE/LYS in Arf6 KO cells.
(a) Normalized integrated densities of PI4P staining (see d) of Arf6 KO cells treated with DMSO (100±9%,±indicates s.e.m., n¼ 22 cells, 3 experiments)
or PAO (79±4%, n¼ 29 cells, three experiments). *Po0.05 in t-test with Welch’s correction. (b) Bar diagram showing PI4P levels in DMSO- and
PAO-treated Arf6 KO cells. Measurements were made by anionic exchange HPLC with suppressed conductivity detection, expressed in molar percentage of
measured lipids and normalized to DMSO-treated Arf6 KO levels. PI4P levels were decreased in PAO-(63±5%,± indicates s.e.m., n¼4) compared with
DMSO-treated controls (100±1%, n¼4). ***Po0.001 in Student’s t-test. (c) Kinetic following of GFP-SNX6 tubulation in Arf6 KO MEFs treated with
DMSO or PAO by spinning-disk live imaging. Top panel, representative images of Arf6 KO cells after different times of PAO treatment. Arrows indicate
tubules. Scale bar, 5 and 1mm (zoom-ins). Lower panel, quantification of the number of GFP-SNX6 tubules after DMSO (black, n¼ 9 cells, four
experiments) or PAO treatment (red, n¼9 cells, four experiments), normalized to the number of tubules before the treatment. *Po0.05 and ***Po0.001
in two-way ANOVA with Bonferroni post-tests, respectively. (d) Left, representative immunostaining for PI4P (magenta) of Arf6 KO cells treated with
DMSO or PAO and labelled with filipin (blue). Scale bar, 5 mm. Middle, quantification of the absolute number and relative distribution of filipin puncta in
DMSO-(37±3 puncta/cell,±indicates s.e.m., n¼ 37 cells, 4 experiments) or PAO-(30±3 puncta per cell, n¼ 29 cells, four experiments) treated Arf6 KO
cells. NS denotes P40.05 in Student’s t-test. **Po0.01 in w2-test. Right, size of filipin puncta in DMSO-(0.53±0.01mm2,±indicates s.e.m., 1,352 puncta,
37 cells) or PAO-(0.50±0.01mm2, 876 puncta, 29 cells) treated Arf6 KO cells. **Po0.01 in Mann–Whitney test. NS, not significant.
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nucleotide exchange factor for Arf6, interacts with SNX1 and
regulates neurite outgrowth through this interaction, although
neither the role of retromer nor the link with phosphoinositide
signalling and cholesterol homeostasis was addressed in that
context37. In this study, we propose a novel model whereby Arf6
controls the dynamics of retromer tubules in the endosome-to-
TGN pathway responsible for the retrograde transport of CI-
M6PR through negative regulation of an endosomal pool of PI4P
(Fig. 8). Amongst the potential effectors of PI4P, specific
members of the SNX family were considered excellent
candidates based on their lipid-binding specificity. In fact, while
SNX1, SNX2, SNX5 and SNX6 have all been shown to mediate
the retromer-dependent traffic of CI-M6PR transport23,27–30 and
bind to phosphoinositides via both their PX (phox homology)
and BAR (Bin/ amphiphysin/ Rvs) domains, SNX6 appears to be
the only member exhibiting a greater affinity for PI4P than for
other phosphoinositides38, consistent with our findings showing
defects in SNX6-coated tubule dynamics in Arf6 KO cells.
Moreover, PI4P has been shown to compete with the
p150(Glued) subunit of the dynein/dynactin complex for
binding to SNX6 in the TGN38. Since impairing the retromer/
dynein motor coupling causes defects in retromer tubule
fission39,40, an interesting possibility supported by our data is
that the higher levels of PI4P found in the Arf6 KO cells may
enhance the PI4P/SNX6 interaction on endosomal membranes at







































































































































































































































Figure 7 | Lowering PI4P levels through GFP-PIPKIci1 or GFP-Sac2 overexpression rescues cholesterol redistribution in Arf6 KO cells. (a) Left,
representative confocal images of Arf6 KO cells expressing the K188A mutant (top) or the wild-type (bottom) GFP-PIPKIgi1 (green) labelled with filipin
(blue). Scale bar, 5 mm. Center, quantification of the absolute number and relative distribution of filipin puncta in Arf6 KO cells expressing K188A
GFP-PIPKIgi1 (31±4 puncta per cell,±indicates s.e.m., n¼ 24 cells, three experiments) or WT GFP-PIPKIgi1 (18±2 puncta per cell, n¼ 38 cells, five
experiments). **Po0.01 in t-test with Welch’s correction. ***Po0.001 in w2-test. Right, size of filipin puncta in Arf6 KO cells expressing K188A
GFP-PIPKIgi1 (0.51±0.01mm2,±indicates s.e.m., 742 puncta, 24 cells) or WT GFP-PIPKIgi1 (0.42±0.01mm2, 671 puncta, 38 cells). ***Po0.001 in
Mann–Whitney test. (b) Left, representative confocal images of Arf6 KO cells expressing the C458S mutant (top) or the wild-type (bottom) GFP-Sac2
(green) and labelled with filipin (magenta). Scale bar, 5 mm. Center, quantification of the absolute number and relative distribution of filipin puncta in Arf6
KO cells expressing C458S GFP-Sac2 (56±5 puncta per cell,±indicates s.e.m., n¼ 27 cells, three experiments) or WT GFP-Sac2 (35±6 puncta per cell,
n¼ 12 cells, three experiments). *Po0.05 in Student’s t-test. ***Po0.001 in w2-test. Right, size of filipin puncta in Arf6 KO cells expressing C458S
GFP-Sac2 (0.52±0.01mm2, ± indicates s.e.m., 1,517 puncta, 27 cells) or WT GFP-Sac2 (0.48±0.02mm2, 417 puncta, 12 cells). *Po0.05 in
Mann–Whitney test.
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retromer fission defects. Whether the lack of Arf6 and its NH2-
terminal amphipathic helix directly alters membrane tubule
dynamics as described for other Arf family members41,42, and
contributes to retromer tubules defects, remains to be investigated.
Similarly, a perturbation of the PI4P/PI(4,5)P2 ratio on endosomal
membranes may alter the fission efficiency of retromer tubules as we
have previously reported for endocytic structures43.
Our study also further highlights the tight crosstalk between
small GTPases and phosphoinositide metabolism32,44. In the
context of retromer regulation, Rab5 has been shown to control
class III PI3K (ref. 45), whose product PI3P mediates the
recruitment of key components of the retromer assemblies, SNX1
and SNX2 (refs 27–29,46). In contrast, Rab7 directly interacts
with the VPS core complex to facilitate the recruitment of
retromer to endosomal membranes46,47. In this study, we propose
a novel mechanism for GTPase-mediated control of retromer,
involving the negative regulation of endosomal PI4P levels. As
mentioned earlier, Arf6 controls PIPKIs, suggesting that PI(4,5)P2
generation may be key to its biological function. However, the
HPLC profile suggests that it is rather the accumulation of PI4P
on endosomes than a reduction in PI(4,5)P2 which accounts for
the retromer phenotype. This is further supported by our rescue
experiments showing that decreasing PI4P levels, rather than
enhancing PI(4,5)P2 levels, corrects the retromer phenotype
(Figs 6 and 7). In addition, because PIPKIg overexpression
rescues the cholesterol redistribution phenotype, we speculate
that dysregulation of a PIPKI isoform on endosomal membranes
is the basis of PI4P accumulation on these compartments.
However, we cannot rule out contributions of class II PI3Ks,
PI4Ks or PI4P phosphatases to this phenotype, particularly
in light of the presence of some of their isoforms in
the endosomal compartments, including the Sac2 inositol
4-phosphatase34–36,48–55.
While our study further establishes a link between Arf6 and
NPC disease19, it also reports a role of retromer in endolysosomal
cholesterol homeostasis. As retromer has been linked to several
neurodegenerative diseases56 and cholesterol accumulation in
LE/LYS can lead to neurodegeneration57, this raises the
question of the importance of the link between retromer and
cholesterol in neurodegeneration. It is particularly intriguing that
both decreased retromer levels58 and increased cholesterol
levels59,60 have been linked to late-onset Alzheimer’s disease.
Further studies should give us insights into the role of the novel
Arf6/retromer/cholesterol connection in the aetiology of
neurodegenerative diseases.
Methods
Reagents. DMSO, tamoxifen, filipin, phenylarsine oxide (PAO) and bovine serum
albumin (BSA) were purchased from Sigma-Aldrich. Saponin was from Acros.
Antibodies and peptides. The antibody against Arf6 (ref. 61) was a kind gift from
Julie Donaldson (NIH, Bethesda, MD; 1/1000 for western blots). The other
antibodies were obtained from the following sources: rabbit antibodies to LAMP1
(ab24170, Abcam, 1/500 in immunofluorescence (IF), 1/500 for western blots),
Rab7 (9367, Cell Signalling Technology, 1/100 in IF), EEA1 (3288, Cell Signalling
Technology, 1/400 in IF), NPC1 (ab36983, Abcam, 1/500 for western blots), NPC2
(sc-33776, Santa Cruz, 1/50 in IF and H00010577-D01P, Abnova, 1/100 for
western blots), M6PR (PA3-850, Thermo, 1/100 in IF), Golgin97 (13192, Cell
Signalling Technology, 1/100 in IF); goat polyclonal antibodies to SNX1 (ab99286,
Abcam, 1/50 in IF), SNX6 (sc-8679, Santa Cruz, 1/50 in IF) and Vps35 (ab10099,
Abcam, 1/150 in IF); rat monoclonal antibodies (mABs) to LAMP1 (sc-19992,
Santa Cruz, 1/50 in IF) and HA (3F10, Roche, 1/200 in IF); mouse monoclonal
antibodies to tubulin (T5168, Sigma, 1/1000 for western blots), NPC2 (sc-166449,
Santa Cruz, 1/50 in IF), Vps35 (ab57632, Abcam, 1/300 in IF, 1/1,000 for western
blots) and PI4P (Z-P004, Echelon, 1/100 in IF). Purified NPC2-Alexa488 (ref. 62)
was a kind gift from Ling Huang and Peter Lobel (Rutgers University, Piscataway,
NJ). Peroxidase-conjugated secondary antibodies were from Biorad and were used
at a dilution 1/3,000. Alexa-conjugated fluorescent secondary antibodies were from
Life Technologies (1/400 for Alexa 488 and Alexa 555; 1/300 for Alexa 647).
Plasmids and RNA interference. NPC1-GFP was kindly provided by Kara
Primmer and Kevin Vaughan (University of Notre Dame, Notre Dame, IN)63.
GFP-SNX6 was kindly provided by Peter Cullen (University of Bristol, UK)30.
ARF6-HA3 was kindly provided by Julie Donaldson (NIH, Bethesda, MD) and
CyPET-ARF6 (ref. 31) was a kind gift from Martin Schwartz (Addgene plasmid
# 18840). GFP-Sac2 and its phosphatase-dead mutant GFP-Sac2 C458S were kind
gifts from Yuxin Mao (Cornell University, Ithaca, NY)35. GFP-PIPKIgi1 and its
kinase-dead mutant GFP-PIPKIgi1-K188A were previously published64. All DNA
sequences were checked by sequencing. VPS35 knockdown (KD) was performed
with a 1:1 mix of Qiagen Flexitube siRNA Human VPS35_5 (SI04268131)
and Human Vps35_6 (SI04279296). SNX1 and SNX2 double knockdowns
were performed with a 1:1 mix of ON-TARGET plus Human SNX1 (6642)
siRNA-SMART pool and ON-TARGET plus Human SNX2 (6643) siRNA-SMART
pool (GE Dharmacon). SNX5 and SNX6 double knockdowns were performed with
a 1:1 mix of ON-TARGET plus Human SNX5 (27131) siRNA-SMART pool and
ON-TARGET plus Human SNX6 (58533) siRNA-SMART pool (GE Dharmacon).
Generation of Arf6Flox/Flox mice. To generate Arf6 conditional KO mice, the
entire coding sequence (B4,000 bp) was flanked with loxP sites, with one (loxP)
sub-cloned into a targeting vector upstream of the Arf6 coding region at the SspI
site and a FRT-NEO-FRT-loxP cassette inserted downstream of the Arf6 sequence
at the XhoI site. The targeting vector was electroporated into ES cells and
successfully targeted ES cells were microinjected into blastocysts, which were then
transferred into foster mothers for the generation of chimeric mice. Resultant
Arf6Flox-Neo/þ mice were crossed with Flp Deleter mice (ACTB-Flpe from The
Jackson Laboratory, Stock 005703) to generate Arf6Flox/þ mice. These mice were
then crossed with the inducible Cre-ER mice (Rosa B6Cre-ER/Cre-ER from the
Jackson Laboratory, Stock 008463), to generate Arf6Flox/þ ;Cre-ER mice, which
were then interbred to generate Arf6Flox/Flox;Cre-ER mice. Animals were used in
full compliance with National Institutes of Health/ Institutional Animal Care and
Use Committee guidelines. Specifically, adult mice were sacrificed via inhalation of
carbon dioxide, followed by cervical dislocation, while embryos derived from the
killed mothers were decapitated after inducing hypothermia on ice. The animal
protocols were approved by the Committee on the Ethics of Animal Experiments of
Columbia University. Arf6Flox/þ mice were made available to The Jackson
Laboratory.
Cell cultures and transfection. Immortalized MEFs and HeLa cells were
maintained at 37 C in a humidified 5% CO2 atmosphere in DMEM with Glutamax
supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin
(all from Life technologies). Cells were negative for mycoplasma contamination.


















Figure 8 | Model of Arf6 regulation of cholesterol homeostasis.
Arf6 controls an endosomal pool of PI4P and regulates retromer tubules
dynamics in the endosome-to-TGN pathway, consequently impacting
CI-M6PR and NPC2 localization (see also text). PAO: PI4K inhibitor.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11919 ARTICLE
NATURE COMMUNICATIONS | 7:11919 | DOI: 10.1038/ncomms11919 | www.nature.com/naturecommunications 11
Torsos from Arf6Flox/Flox;Cre-ER embryos were minced and trypsinized for 15min
and homogenized by pipetting. MEFs were immortalized by multiple passaging and
were used for experiments after 25 passages. Arf6Flox/Flox;Cre-ER MEFs contain a
Cre-oestrogen receptor (Cre-ER) fusion protein, rendering Cre recombinase
inducible by tamoxifen65. Arf6Flox/Flox;Cre-ER MEFs were plated at a high density
and treated the next day with DMSO or 10 mM tamoxifen. After 72 h, cells were
split in fresh media and left in culture for another 72 h. Arf6 deletion was complete
by then. All experiments were performed between 3 and 7 days after complete Arf6
deletion. MEFs were transiently transfected using Lipofectamine LTX (Life
Technologies) and protein expression was assessed after 24 or 48 h. HeLa cells were
transfected using Lipofectamine 2000 (Life Technologies). Protein expression was
assessed after 24 or 48 h and knockdowns were assessed at 72 h.
Anionic phospholipid analysis. Phosphoinositides and other anionic phospho-
lipids were measured as deacylated lipids using anionic exchange HPLC with
suppressed conductivity detection66,67. Samples were prepared from cells grown to
half-confluency in 100-mm dishes, washed with ice-cold HBSS and processed for
phosphoinositide enrichment, followed by deacylation66,67.
Free cholesterol analysis. Free cholesterol levels (and other lipids) were
measured by separating complex lipid mixtures by reverse phase HPLC, followed
by detection using multiple reactions monitoring68. Samples were prepared from
cells grown to half-confluency in 60-mm dishes, washed with ice-cold HBSS
and processed for lipid extraction using a modified Bligh and Dyer protocol68.
Free cholesterol levels were quantified by referencing a D7-cholesterol
(Avanti Polar Lipids) internal standard that was spiked into each sample before
the analysis.
Immunofluorescence and filipin staining. For NPC2 uptake experiments, MEFs
were exposed to fresh medium containing PBS (Boston BioProducts) or purified
NPC2-Alexa488 (ref. 62) 60 nM for 24 h, rinsed twice with HBSS (Life
Technologies) and fixed. For PAO experiments, MEFs were exposed to fresh
medium containing DMSO or PAO 1 mM for 30min at 37 C, rinsed twice with
HBSS and fixed. For immunofluorescence experiments, cells grown on glass
coverslips were washed once with HBSS and fixed with 4% paraformaldehyde
(Electron Microscopy Sciences) for 20min at room temperature or at 37 C (when
preservation of the tubular structures was crucial). Cells were then washed twice in
HBSS and incubated with NH4Cl (50mM in PBS) for 10min. For NPC2 staining,
cells were fixed for 1 h in Bouin’s solution (Sigma-Aldrich). Cells were then washed
twice in PBS and permeabilized with solution A (saponin 0.05%, BSA 5% in PBS)
for at least 45min at 37 C. They were then incubated with primary antibodies
diluted in solution A for 1 h at room temperature, washed three times in solution
A, incubated with fluorescent secondary antibodies diluted in solution A for 1 h at
room temperature and washed again three times in solution A. An extra step was
performed for filipin staining. Cells were washed once in PBS, incubated in filipin
(0.5mgml 1 in PBS) for 1 h at room temperature and washed twice with PBS.
Cells were finally washed once with PBS and coverslips were mounted in
Vectashield mounting medium (Vectorlabs).
Confocal microscopy. Z-stacks were acquired by confocal laser scanning micro-
scopy (Zeiss LSM 700). Fluorescence was collected with a  63 plan apochromat
immersion oil objective (numerical aperture (NA) 1.4). Extraction of single z-frame
and maximum intensity projections were performed with the ImageJ software.
Integrated densities, that is, cell area [(mean cell intensities summed on the
whole z-stack)–(mean background intensities summed on the whole z-stack)],
were measured with Image J software. Z-stack co-localization percentage, that is,
 100 (Pearson’s coefficient)2, were obtained with the JACoP plugin of ImageJ69.
The number and size of puncta were quantified with ICY software70. We checked
that the cells we were comparing for fluorescence intensity, size and number of
organelles or co-localization had comparable areas (P40.05 in Student’s t-test).
Each experiment was independently repeated at least three times, resulting in the
analysis of 22 to 42 cells for each condition.
3D Structured illumination microscopy. Cells were grown on high performance
#1.5 coverslips (Zeiss). Immunofluorescence was performed as described for
confocal microscopy but secondary antibodies were used twice as concentrated
(1/200) and coverslips were mounted in ProLong Gold (Life technologies).
Z-stacks were acquired on a Nikon N-SIM microscope equipped with an
iXon Ultra 897 camera (Andor) and a  100 plan apochromat immersion oil
objective (NA 1.49). Image reconstruction and analysis were performed with
the NIS-Elements software.
Spinning-disk confocal live imaging. Cells were grown in 35-mm glass-bottom
dishes (MatTek) and imaged 48 h after transfection. Before imaging, medium was
replaced to get rid of any debris and to ensure accuracy of volume for the PAO
experiments. For kinetic PAO experiments, Arf6 KO cells expressing GFP-SNX6
were imaged for 2min and their localization recorded. At time 0, DMSO or PAO
(1 mM final) diluted in medium was added to the cells and three movies of 2min
were recorded (before 15min, between 15 and 30min and between 30 and 45min).
Only cells displaying at least two tubules at time 0 were kept for analysis. Live
imaging was carried out using a Nikon Ti Eclipse microscope equipped with a
Yokogawa CSU-X1 spinning-disk, a motorized stage and a Photometrics Evolve
512 camera (Roper Scientific) controlled with the NIS-Elements software. Movies
were acquired at 37 C and 5% CO2 with a Tokai Hit stage-top incubator and
objective heater. Fluorescence was collected with a 60 plan apochromat
immersion oil objective (NA 1.49). Images were collected at 1 1 binning with
an exposure time of 100ms. The number, maximum length and persistence of
GFP-SNX6 tubules were analysed with ImageJ software.
Protein biochemistry and immunoblotting. Cells were washed with ice-cold
HBSS, scraped and centrifuged for 10min at 16,000 g at 4 C. Pellets were
resuspended in RIPA buffer (Pierce) complemented with cOmplete protease
inhibitor cocktail (Roche) and proteins were extracted on a wheel at 4 C for at
least 30min. Samples were then centrifuged for 15min at 16,000 g and proteins in
the supernatant were processed for protein dosage (BCA, Pierce). SDS–PAGE
was performed on samples (15mg total proteins) loaded in NuPAGE 4–12%
Bis-Tris gels (Life technologies). For quantification, wet transfer was performed at
40V for 135min at 4 C (Bio-Rad). For Arf6 deletion confirmation, transfer was
performed with iBlot (Life Technologies). Primary and secondary antibodies
were incubated overnight at 4 C and 45min at room temperature, respectively.
Revelation was performed with Immobilon Western Chemiluminescent HRP
Substrate (EMD Millipore) and the chemiluminescent signal was imaged with
ImageQuant LAS4000 mini (GE Healthcare). Quantification was performed
with ImageJ. Uncropped blots are shown in Supplementary Fig. 9.
Statistical analysis. Statistical calculations were performed using GraphPad
Prism software (version 5.02). All the data are given as mean±s.e.m. In most cases,
when comparing two samples, two-tailed Student’s t-test was performed. If a clear
hypothesis was postulated that made it valid, then we used a one-tailed t-test.
When variances were not comparable, Welch’s correction was applied. When the
distribution could not be assumed to be Gaussian (for compartments size), we used
a non parametric Mann–Whitney test. When more samples were compared and
Bartlett’s test showed that variances could be compared, we used one-way ANOVA
or two-way ANOVA with Bonferroni post-tests. If variances could not be com-
pared (P value in Bartlett’s testo0.05), then we used t-tests. Chi-square test was
used to compare distributions. Outliers, defined as values that were superior to
(meanþ 3 s.d.) or inferior to (mean 3 s.d.) were excluded.
Data availability. The authors declare that all the data supporting the findings of
this study are available within the article and its Supplementary Information files
or are available from the corresponding authors on request. Arf6Flox/þ mice
generated in this study have been made available to the Jackson Laboratory.
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